HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 81 filers reported holding HILLEVAX INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,610,135 | +5.9% | 595,445 | +21.8% | 0.00% | – |
| Q1 2024 | $8,127,646 | +21.4% | 488,734 | +17.1% | 0.00% | – |
| Q4 2023 | $6,696,798 | +39.8% | 417,246 | +17.2% | 0.00% | – |
| Q3 2023 | $4,788,604 | -21.3% | 356,030 | +0.6% | 0.00% | – |
| Q2 2023 | $6,080,928 | +34.7% | 353,748 | +29.6% | 0.00% | – |
| Q1 2023 | $4,513,302 | -48.2% | 273,037 | -47.6% | 0.00% | – |
| Q4 2022 | $8,712,014 | +132.6% | 520,742 | +137.6% | 0.00% | – |
| Q3 2022 | $3,745,000 | +108.8% | 219,137 | +33.5% | 0.00% | – |
| Q2 2022 | $1,794,000 | – | 164,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,781,472 | $161,687,732 | 11.71% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $9,238,997 | 11.18% |
| Samsara BioCapital, LLC | 609,862 | $10,081,019 | 2.08% |
| StepStone Group LP | 676,569 | $11,183,686 | 2.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,833,690 | $46,840,896 | 1.04% |
| Carlyle Group Inc. | 1,838,486 | $30,096,016 | 0.90% |
| BRAIDWELL LP | 1,620,216 | $26,782,170 | 0.88% |
| RA Capital Management | 1,760,019 | $29,093,114 | 0.66% |
| Perceptive Advisors | 406,024 | $6,711,577 | 0.20% |
| BVF INC/IL | 248,579 | $4,109,011 | 0.15% |